Tcg Crossover Management, LLC Centessa Pharmaceuticals PLC Transaction History
Tcg Crossover Management, LLC
- $612 Million
- Q4 2024
A detailed history of Tcg Crossover Management, LLC transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 2,890,816 shares of CNTA stock, worth $48.4 Million. This represents 7.91% of its overall portfolio holdings.
Number of Shares
2,890,816
Previous 2,890,816
-0.0%
Holding current value
$48.4 Million
Previous $46.2 Million
4.75%
% of portfolio
7.91%
Previous 6.0%
Shares
2 transactions
Others Institutions Holding CNTA
# of Institutions
118Shares Held
124MCall Options Held
7KPut Options Held
220K-
Medicxi Ventures Management (Jersey) LTD20MShares$334 Million73.44% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$167 Million99.89% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$162 Million5.81% of portfolio
-
Perceptive Advisors LLC New York, NY6.35MShares$106 Million3.55% of portfolio
-
First Light Asset Management, LLC Edina, MN5.81MShares$97.2 Million9.51% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.58B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...